[go: up one dir, main page]

TN2019000064A1 - Composition comprising multivalent capsular polysaccharide-transport protein and use thereof - Google Patents

Composition comprising multivalent capsular polysaccharide-transport protein and use thereof

Info

Publication number
TN2019000064A1
TN2019000064A1 TNP/2019/000064A TN2019000064A TN2019000064A1 TN 2019000064 A1 TN2019000064 A1 TN 2019000064A1 TN 2019000064 A TN2019000064 A TN 2019000064A TN 2019000064 A1 TN2019000064 A1 TN 2019000064A1
Authority
TN
Tunisia
Prior art keywords
capsular polysaccharide
composition
transport protein
multivalent
multivalent capsular
Prior art date
Application number
TNP/2019/000064A
Inventor
Hoon Sung Jeh
Tae Hyun Kim
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Publication of TN2019000064A1 publication Critical patent/TN2019000064A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a vaccine composition for preventing pneumococcal diseases and an immunogenic composition against Streptococcus pneumoniae, which contains 13 or 14 types of capsular polysaccharide-carrier protein conjugates.
TNP/2019/000064A 2016-09-06 2017-08-31 Composition comprising multivalent capsular polysaccharide-transport protein and use thereof TN2019000064A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160114591 2016-09-06
PCT/KR2017/009569 WO2018048141A1 (en) 2016-09-06 2017-08-31 Composition comprising multivalent capsular polysaccharide-transport protein and use thereof

Publications (1)

Publication Number Publication Date
TN2019000064A1 true TN2019000064A1 (en) 2020-07-15

Family

ID=61561397

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP/2019/000064A TN2019000064A1 (en) 2016-09-06 2017-08-31 Composition comprising multivalent capsular polysaccharide-transport protein and use thereof

Country Status (12)

Country Link
KR (1) KR101991457B1 (en)
BR (1) BR112019004303A2 (en)
EA (1) EA201990451A1 (en)
JO (1) JOP20190038B1 (en)
MA (1) MA45283B1 (en)
MX (1) MX2019002552A (en)
MY (1) MY192792A (en)
PH (1) PH12019500377B1 (en)
SA (1) SA519401232B1 (en)
TN (1) TN2019000064A1 (en)
WO (1) WO2018048141A1 (en)
ZA (1) ZA201901969B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018400751B2 (en) 2017-12-06 2022-07-21 Merck Sharp & Dohme Llc Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
EP3749357A4 (en) 2018-02-05 2022-04-20 Sanofi Pasteur, Inc. COMPOSITION OF MULTIVALENT POLYSACCHARIDE-PNEUMOCOCCAL PROTEIN CONJUGATES
KR20190121713A (en) * 2018-04-18 2019-10-28 에스케이바이오사이언스(주) Capsular saccharide of Streptococcus pneumoniae and the immunogenic conjugates thereof
CN119971019A (en) 2018-12-19 2025-05-13 默沙东有限责任公司 Compositions containing pneumococcal polysaccharide-protein conjugates and methods of use thereof
IL316477A (en) * 2022-05-11 2024-12-01 Pfizer Process for producing of vaccine formulations with preservatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2210262T3 (en) * 1993-09-22 2004-07-01 Henry M. Jackson Foundation For The Advancement Of Military Medicine PROCEDURE THAT ALLOWS THE ACTIVATION OF A SOLUBLE GLUCIDE WITH THE HELP OF NEW CIANILANT REAGENTS TO PRODUCE IMMUNOGEN STRUCTURES.
CA2986862C (en) * 2005-04-08 2022-09-27 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
SI2575870T1 (en) * 2010-06-04 2017-01-31 Wyeth Llc Vaccine formulations
KR102057217B1 (en) * 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 Multivalent pneumococcal polysaccharide-protein conjugate composition
CN103893751B (en) * 2014-03-26 2016-04-20 天津康希诺生物技术有限公司 A kind of pneumococal polysaccharide Protein Conjugation vaccine and preparation method thereof
CN104069504B (en) * 2014-05-11 2019-09-24 江苏康泰生物医学技术有限公司 A method of enhancing polysaccharide protein conjugate immunogenicity

Also Published As

Publication number Publication date
MY192792A (en) 2022-09-09
EA201990451A1 (en) 2019-08-30
WO2018048141A1 (en) 2018-03-15
MA45283B1 (en) 2021-05-31
KR20180027353A (en) 2018-03-14
MX2019002552A (en) 2019-07-01
JOP20190038B1 (en) 2023-09-17
PH12019500377B1 (en) 2024-05-15
PH12019500377A1 (en) 2019-10-21
SA519401232B1 (en) 2022-10-23
KR101991457B1 (en) 2019-09-30
JOP20190038A1 (en) 2019-03-06
BR112019004303A2 (en) 2019-05-28
MA45283A1 (en) 2019-06-28
ZA201901969B (en) 2019-12-18

Similar Documents

Publication Publication Date Title
PH12021550318A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
IL265623A (en) Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates
MX382438B (en) Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
MX2020002556A (en) Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates.
PH12018500037A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
MX371453B (en) Streptococcus pneumoniae capsular polysaccharides and conjugates thereof.
TN2019000064A1 (en) Composition comprising multivalent capsular polysaccharide-transport protein and use thereof
MX2021014948A (en) METHODS OF TREATING PATIENTS WITH AN IMMUNOGENIC COMPOSITION THAT PROTECTS AGAINST <i>S. PNEUMONIAE</i> SEROTYPE 29.
MX2016003621A (en) Protein and peptide-free synthetic vaccines against streptococcus pneumoniae type 3.
ZA202103560B (en) Multivalent pneumococcal polysaccharide-protein conjugate vaccine
IL276661A (en) Immunogenic composition comprising staphylococcal antigens
PH12018501205A1 (en) Synthetic vaccines against streptococcus pneumoniae serotype 2
HK40050226B (en) Multivalent pneumococcal polysaccharide-protein conjugate vaccine